FDA Publishes Full Texts of Response Letters to Drug Applications
The goal is to improve public understanding of the FDA decision-making process
AI Better for Tumor-Infiltrating Lymphocyte Quantification in Melanoma Than Traditional Methods
Machine learning algorithm has superior reproducibility and prognostic associations compared with traditional pathologist-read methods
Review Compares Efficacy, Safety of Treatments for Hidradenitis Suppurativa
Differences between adalimumab and other targeted treatments mainly not significant
Health Care Expenditure Expected to Top GDP Growth 2024 to 2033
National health care expenditure growth expected to outpace GDP, resulting in a health share of GDP that reaches 20.3 percent by 2033
Men With Hidradenitis Suppurativa Perceive Better Physician Communication
Female patients perceive that clinicians are significantly worse at demonstrating respect, listening, and explaining concepts
27.2 Million People of All Ages Uninsured in 2024 in the United States
Nonsignificant increase seen from 2023; 11.6 percent of adults aged 18 to 64 and 5.1 percent of children aged 0 to 17 were uninsured in 2024
Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa
One-time surgical application of prademagene zamikeracel improves wound healing and pain
Insurers Promise to Speed Up Delays in Health Care Approvals
Nearly 30 People in England Get Rare Illness After Botox
FDA Approves Dupixent for Bullous Pemphigoid
Benefits include sustained disease remission, reductions in itch, lower oral corticosteroids dose
